Prognostic impact of PD-1 and its ligands in renal cell carcinoma

Erlmeier F, Weichert W, Schrader AJ, Autenrieth M, Hartmann A, Steffens S, Ivanyi P (2017)

Publication Type: Journal article

Publication year: 2017

Journal

Medical Oncology Humana Press

Book Volume: 34

Pages Range: 99

Journal Issue: 6

DOI: 10.1007/s12032-017-0961-y

Abstract

Programmed death-1 receptor (PD-1) and programmed death-1 receptor-ligand (PD-L1) have been suggested to play a role as prognostic markers in clear cell renal cell carcinoma (ccRCC). The association between PD-L1 and prognosis seems to be more robust than for PD-1. Further, preliminary analyses suggest that neither PD-1 nor its ligands play a role as prognostic markers in non-clear cell RCC, while the prognostic role of PD-L2 in ccRCC as well as in non-clear cell RCC remains unclear.

Authors with CRIS profile

Arndt Hartmann Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Involved external institutions

Medizinische Hochschule Hannover (MHH) / Hannover Medical School DE Germany (DE) KfH-Nierenzentrum Jena DE Germany (DE) Technische Universität München (TUM) DE Germany (DE)

How to cite

APA:

Erlmeier, F., Weichert, W., Schrader, A.J., Autenrieth, M., Hartmann, A., Steffens, S., & Ivanyi, P. (2017). Prognostic impact of PD-1 and its ligands in renal cell carcinoma. Medical Oncology, 34(6), 99. https://doi.org/10.1007/s12032-017-0961-y

MLA:

Erlmeier, Franziska, et al. "Prognostic impact of PD-1 and its ligands in renal cell carcinoma." Medical Oncology 34.6 (2017): 99.

BibTeX: Download